Salarius Pharmaceuticals

Salarius Pharmaceuticals

Salarius is an epigenetic-focused oncology company developing targeted cancer therapies for pediatric, rare and other cancers. More specifically, Salarius is developing novel therapeutics that interrupt epigenetic programs. Their first indication is Ewing sarcoma. Second indication is Castration Resistant Prostate Cancer. 

Area of focus: 
Oncology
Commencement date: 
08/01/2016

Contact

  • Ruolan Han, PhD

    Associate Director, Nonclinical Development

Share